Growth Dynamics in the Biomedical/Biotechnology System

Small Business Economics

Volumn 20, Issue 4, 2003, Pages 287-303

  Çetindamar, Dilek ^a   Laage Hellman, Jens ^b  

^a SABANCI UNIVERSITY   (Turkey)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0037247986     PISSN: 0921898X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022959109782     Document Type: Review

References (44)

1. Acharya, R., 1998, 'Conclusions: Biotechnology and European Competitiveness', in J. Senker and R. V. Vliet (eds.), Biotechnology and Competitive Advantage, Cheltenham, U.K.: Edward Elgar.
2. Arrow, K. J., 1962, 'The Economic Implications of Learning by Doing', Review of Economic Studies 29(80), 155-173.
3. Audretsch, D. B. and M. P. Feldman, 1996, 'R&D Spillovers and the Geography of Innovation and Production', American-Economic-Review 86(3), 30-40.
4. Baunach, D. C., M. P. Furgalus and L. K. Shesser, 1993, 'Biotechnology: What's ahead for Ohio?', Ohio Journal of Science 93, 2-6.
5. Battelle, 1993, Ohio's Technology Strengths, a Report to the Ohio Science and Technology Council. Columbus: Battelle.
6. Berry, D., 1996, 'Technological Innovation and Diffusion in Cleveland's Biomedical/Biotechnology Industries', mimeo, Case Western Reserve University.
7. Biemans, W. G., 1992, Managing Innovation within Networks, London: Routledge.
8. Carlsson, B. and R. Stankiewicz, 1991, 'On the Nature, Function, and Composition of Technological Systems', Journal of Evolutionary Economics 1(2), 93-118.
9. Carlsson, B. and G. Eliasson, 1995, 'The Nature and Importance of Economic Competence', in B. Carlsson (ed.), Technological Systems and Economic Performance: The Case of Factory Automation, Dordrecht: Kluwer Academic Publishers.
10. Carlsson, B., 1997, 'Four Technological Systems: What Have We Learned?', in B. Carlsson (ed.), Technological Systems: Cases, Analyses, Comparisons, Dordrecht: Kluwer Academic Publishers.
11. Carlsson, B. and S. Jacobsson, 1997, 'Diversity Creation and Technological Systems: A Technology Policy Perspective', in C. Edquist (ed.), Systems of Innovation: Technologies, Institutions and Organizations, London: Pinter Publishers.
12. Carlsson, B. and P. Braunerhjelm, 1998, 'Industry Clusters: Biotechnology/Biomedicine and Polymers in Ohio and Sweden', in D. Audretsch and R. Thurik (eds.), Innovation, Industry Evolution and Employment, Cambridge: Cambridge University Press.
13. Carlsson, B., New Technological Systems in the Bio Industries-An International Study, Dordrecht: Kluwer Academic Publishers, forthcoming.
14. EBTC, 1994, Biotechnology Development and Company Formation in Ohio, June, Special Report, Cleveland: EBTC.
15. EBTC, 1998, The Directory of Edison Biotechnology Center, Cleveland, Ohio: EBTC.
16. Eliasson, G., 1997, The Venture Capitalist as a Competent Outsider, KTH/ IEO/ R-97/ 6-SE, Stockholm: the Royal Institute of Technology.
17. Goetz, S. J. and R. S. Morgan, 1995, 'State Level Locational Determinants Of Biotechnology Firms', Economic Development Quarterly 9(2), 174-184.
18. Granberg, A., 1997, 'Mapping the Cognitive and Institutional Structures of an Evolving Advanced-Materials Field: The Case of Powder Technology', in B. Carlsson (ed.), Technological Systems: Cases, Analyses, Comparisons, Dordrecht: Kluwer Academic Publishers.
19. Grönberg, A-M., 1996, Nordiska Företag i Medicinsk Teknik (Nordic Firms in Medical Technology), Huddinge: Bioprint Publishing and Consulting AB.
20. Jaffe, A. B., M. Trajtenberg and R. Henderson, 1993, 'Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations', Quarterly Journal of Economics 100(3), 577-598.
21. Karaömerlioglu, D. C. and S. Jacobsson, 2000, 'The Swedish Venture Capital Industry - an Infant, Adolescent or Grown-up?', Venture Capital 2(1), 61-88.
22. Karaömerlioglu, D. C. and Å. Lindholm-Dahlstrand, 1999, 'Dynamics of Innovation Financing in Sweden', 44th ICSB World Conference (International Conference for Small Business), 20-23 June, Naples, Italy.
23. Keeble, D. and R. Oakey, 1997, 'Spatial Variations in Innovation in High Technology Small and Medium-Sized Enterprises: A Review', in A. Cosh and A. Hughes (eds.), Innovation: National Policies, Legal Perspectives and the Role of Smaller Firms, London: Edward Elgar.
24. Laage-Hellman, J., 1998, 'Den Biomedicinska Industrin i Sverige' (The Biomedical Industry in Sweden), NUTEK B 1998:8, Stockholm: Swedish National Board for Technical and Industrial Development.
25. Lindholm-Dahlstrand, Å., 1997, 'Spin-Off and Acquisition of Small Technology-Based Firms', in J. Evans and M. Klofsten (eds.), Technology, Innovation and Enterprise: The European Experience, London: Macmillan Press.
26. Lindholm-Dahlstrand, Å., 1998, 'Incubators for Small Technology-Based Firms', paper presented at the Sixth Annual High Technology Small Firms Conference, 4-5 June 1998, University of Twente, Enschede, the Netherlands.
27. Lundkvist, U. and Sjöberg, B. (eds.), 1999, Biologi och Teknik i Samverkan: Kompetensområden för en Bredare Industriell Bas (Biology and Technology in cooperation: competence areas for a broader industrial base)', Stockholm: Swedish National Board for Technical and Industrial Development.
28. Martin, P. and S. Thomas, 1998, 'The Commercialization Gap In Gene Therapy: Lessons For European Competitiveness', in J. Senker and R. V. Vliet (eds.), Biotechnology and Competitive Advantage, Cheltenham, U.K.: Edward Elgar.
29. McGrath, K., 1994, Current State of the Biomedical Technology Industries of Greater Cleveland and Recommendations for Future Development, A report prepared for EBTC, May 9, Cleveland: EBTC.
30. Nilsson, A., 1998, Biotechnology Firms in Sweden: The Emergence of a New Business Model, Centre for Medical Innovations, Stockholm: The Karolinska Institute.
31. Peth-Pierce, R., 1995, What Would You Do To Help Biotech?, A report prepared for EBTC, May 16, Cleveland: EBTC.
32. Porter, M. E., 1990, The Competitive Advantage of Nations, New York: The Free Press.
33. Prahalad, C. K. and G. Hamel, 1990, 'The Core Competence of the Corporation', Harvard Business Review 69(3), 79-91.
34. Saviotti, P. P., 1998, 'Industrial Structure and the Dynamics of Knowledge Generation in Biotechnology', in J. Senker and R. V. Vliet (eds.), Biotechnology and Competitive Advantage, Cheltenham, U.K.: Edward Elgar.
35. Saxenian, A., 1994, Regional Advantage: Culture and Competition in Silicon Valley and Route 128, Cambridge, MA: Harvard University Press.
36. SBA, 1999, Http://Www.Sba.Gov/SBIR/Otacc.Html.
37. Senker, J., 1996, 'National Systems of Innovation, Organizational Learning and Industrial Biotechnology', Technovation 16(5), 219-229.
38. Senker, J. and R. V. Vliet (eds.), 1998, Biotechnology and Competitive Advantage, Cheltenham, U.K.: Edward Elgar.
39. Sharp, M., S. Thomas, and P. Martin, 1993, 'Chemicals and Biotechnology', Working Paper, STEEP. Brighton: SPRU.
40. Shaw, B., 1991, 'Developing Technological Innovations within Networks', Entrepreneurship and Regional Development 3, 111-128.
41. Swann, G. M. P., M. Prevezer and D. Stout, 1998, The Dynamics of Industrial Clustering, Oxford: Oxford University Press.
42. Tson Söderström, H., 2001, Kluster.se: Sverige i den ny ekonomiska geografin (Cluster.se: Sweden in the new economic geography), Stockholm: SNS Förlag.
43. U.K. Department of Trade and Industry, 1999, 'Biotechnology Clusters: Report of a Team Led by Lord Sainsbury, Minister for Science', http://www.dti.gov.uk/biotechclusters.
44. Zucker, L. M., M. Darby and M. Brewer, 1994, 'Intellectual Capital and the Birth of U.S. Biotechnology Enterprises', Working Paper No. 4653, National Bureau of Economic Research.